Volume 7, Issue 6 p. 908-919
Open Access

Optimal window of caloric restriction onset limits its beneficial impact on T-cell senescence in primates

Ilhem Messaoudi

Ilhem Messaoudi

Vaccine and Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA

Search for more papers by this author
Miranda Fischer

Miranda Fischer

Vaccine and Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA

Search for more papers by this author
Jessica Warner

Jessica Warner

Vaccine and Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA

Search for more papers by this author
Buyng Park

Buyng Park

Biostatistics Shared Resource, Oregon Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Search for more papers by this author
Julie Mattison

Julie Mattison

Department of Immunobiology and the Arizona Center on Aging, College of Medicine, University of Arizona, Tucson, AZ, USA

Search for more papers by this author
Donald K. Ingram

Donald K. Ingram

Laboratory of Experimental Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA

Pennington Biomedical Research Institute, Louisiana State University, Baton Rouge, LA, USA

Search for more papers by this author
Thomas Totonchy

Thomas Totonchy

Vaccine and Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA

Search for more papers by this author
Motomi Mori

Motomi Mori

Biostatistics Shared Resource, Oregon Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Search for more papers by this author
Janko Nikolich-Žugich

Janko Nikolich-Žugich

Vaccine and Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA

Department of Immunobiology and the Arizona Center on Aging, College of Medicine, University of Arizona, Tucson, AZ, USA

Search for more papers by this author
First published: 24 November 2008
Citations: 44

Janko Nikolich-Žugich, Department of Immunobiology and Arizona Center on Aging, College of Medicine, University of Arizona, 1656 E Mabel St., Tucson, AZ 85724, USA. Tel. 520 626 6065; e-mail: [email protected].

Summary

We have recently shown in non-human primates that caloric restriction (CR) initiated during adulthood can delay T-cell aging and preserve naïve CD8 and CD4 T cells into advanced age. An important question is whether CR can be initiated at any time in life, and whether age at the time of onset would modulate the beneficial effects of CR. In the current study, we evaluated the impact of CR started before puberty or during advanced age on T-cell senescence and compared it to the effects of CR started in early adulthood. Our data demonstrate that the beneficial effects of adult-onset CR on T-cell aging were lost by both early and late CR onset. In fact, some of our results suggest that inappropriate initiation of CR may be harmful to the maintenance of T-cell function. This suggests that there may be an optimal window during adulthood where CR can delay immune senescence and improve correlates of immunity in primates.

Introduction

Human life expectancy has increased worldwide, with the most dramatic gains achieved in the developed world. Thus, in the USA, elderly individuals (over the age of 65) currently make up 13% of the population and that number is projected to reach 20% by the year 2020. An obvious, but uniquely complex and multilayered, challenge for medical and biomedical scientists is to reduce morbidity and mortality and improve health and quality of life in this rapidly growing population. One of the most remarkable advances leading to the increase in human lifespan was made by improving sanitary and public health conditions to control infectious diseases. While that has drastically reduced mortality from infectious diseases up to advanced adulthood, infectious diseases remain a significant problem for the elderly, being consistently among the top five leading causes of death (Htwe et al., 2007; Liang & Mackowiak, 2007).

Aging results in a progressive structural alteration and functional decline in multiple organ systems, including a general decline in immunity referred to as immune senescence. Immune senescence is marked by changes in multiple components of the immune system, with the changes in adaptive immunity being the most pronounced and most consistent. These changes include loss of naïve T and B lymphocytes and accumulation of memory phenotype cells, resulting in a dramatic decrease in repertoire diversity (Johnson & Cambier, 2004; Gruver et al., 2007), which is further compounded by the appearance of T- and B-cell clonal expansions (Szabo et al., 2004; Clambey et al., 2007). This loss of naïve lymphocytes coincides with reduced lymphocyte responsiveness to stimulation on a per-cell basis (Miller, 2000), which further contributes to poor responses to infection and vaccination seen in elderly people. Another hallmark of immune senescence is increased production of pro-inflammatory cytokines, including interleukin-6 and tumor necrosis factor-alpha (TNF-α) (Ershler & Keller, 2000), which have the potential to contribute to a wide range of age-related diseases, including, but not limited to, Alzheimer's disease, osteoporosis, atherosclerosis and certain types of cancers (Vasto et al., 2007).

Among the potential interventions to increase lifespan and improve the quality of life and decrease morbidity in the elderly, caloric restriction (CR) has gained status as a frontrunner over the last several decades. CR is the only intervention to date known to increase both the median and maximal lifespan in a wide variety of short-lived species (reviewed in Masoro, 2003; Roth et al., 2007), and to reduce the incidence of age-related diseases. With regard to the function of the immune system, long-term CR was shown to improve several aspects of immune function in laboratory animals (reviewed in Pahlavani, 2004; Nikolich-Žugich & Messaoudi, 2005). Thus, in rodents CR augments immune competence, inhibits age-related dysregulation of cytokine secretion (Effros et al., 1991; Spaulding et al., 1997a), and prevents the accumulation of senescent T cells through the enhancement of apoptosis (Spaulding et al., 1997b). CR also reduced the incidence of autoimmune disease and cancer (Weindruch & Walford, 1982; Weindruch, 1989; Volk et al., 1994).

Despite the plethora of data supporting the beneficial impact of CR on immunological function, our understanding of the mechanisms of action of CR remains incomplete. Thus, while new discoveries keep emerging (Masoro, 2004; Bishop & Guarente, 2007; Medvedik & Sinclair, 2007), we still do not fully understand molecular mechanisms by which CR extends lifespan and promotes health. Similarly, our understanding of the effect of CR in long-lived species, of the impact of CR on primate physiology, and of the plasticity of the aging process in response to CR onset at different points in the lifespan remain incomplete.

An informative series of studies have been forthcoming from the nonhuman primate [rhesus macaques (RM), Macaca mulatta] cohorts established at the National Institute on Aging (NIA) and the Wisconsin National Primate Research Center (Lane et al., 1999; Ramsey et al., 2000). Initial results from these studies have demonstrated that in primates CR exerts many of the same physiological changes seen in rodents (Lane et al., 2001), including a decrease in body weight and fat mass, reduced blood lipids, improved glucoregulatory function and decreased blood pressure (Verdery et al., 1997; Edwards et al., 1998; Cefalu et al., 1999). Furthermore, CR attenuated the age-related decrease in dehydroepiandrosterone and melatonin (Roth et al., 2001) in male RM, and there are indications that similar changes are occurring under CR in humans (Roberts & Schoeller, 2007).

Using the NIA RM cohort, we have recently shown that long-term CR initiated during adolescence [at 3–5 years of age; adolescent-onset CR (AO-CR)] can delay T-cell senescence as measured by higher numbers of circulating naïve T cells, lower numbers of inflammatory cytokine-secreting memory T cells, and higher proliferative capacity (Messaoudi et al., 2006). These changes would be expected to improve immune response to infection and vaccination. However, these results were a significant departure from earlier reports that suggested a decrease in immune function in RM with shorter exposure to CR, specifically lymphopenia and reduced T-cell proliferation to mitogenic stimulus and immunization (Grossmann et al., 1995; Roecker et al., 1996; Weindruch et al., 1997). In addition to length of time on a CR diet, the age of initiation was different between the two study populations. While our earlier study reported on monkeys that began CR between the 3 and 5 years old, the latter study reported on monkeys initiated at 8 to 14 years of age (Kemnitz et al., 1993; Roecker et al., 1996). To address whether the age of CR onset can influence T-cell homeostasis and function in RM, we compared two additional groups of monkeys that began CR either as juveniles [(1–2 years, juvenile-onset CR (JO-CR)] or late in life [(> 15 years, old-onset CR (OO-CR)] to the adult (adolescent) cohort (3–5 years at onset AO-CR) on measures of T-cell senescence. Our results strongly suggest that adult-onset CR improved T-cell function in RM while CR started during early years of development led to accelerated T-cell senescence. Initiation of CR in the advanced age did not have any beneficial effects on T-cell senescence, and, by one parameter, was shown to potentially further erode T-cell proliferative capacity. We conclude that there is an optimal window in the course of which CR interventions can retard aging of the immune system.

Results

Early onset of CR leads to accelerated loss of naïve T cells

Our prior studies showed that CR initiated during early adulthood can significantly delay the age-related loss of naïve T cells (Messaoudi et al., 2006). To determine the impact of age at onset of CR on T-cell homeostasis and subset distribution, we measured the frequency of naïve, central memory (CM) and effector memory (EM) T cells in peripheral blood mononuclear cells (PBMC) isolated from animals that started CR either before puberty (JO-CR) or at an advanced age (OO-CR). These subsets were defined based on the expression of CD28 and CD95 as described previously (Pitcher et al., 2002): naïve T cells are CD28intCD95lo, CM T cells are CD28hiCD95hi, and EM T cells are CD28negCD95hi. We and others have shown that advanced age in humans and nonhuman primates results in loss of naïve T cells from > 40% to < 20% of total circulating T cells (Wikby et al., 1998; Jankovićet al., 2003; Čičin-Sain et al., 2007). This loss is accompanied by an accumulation of EM T cells especially in the CD8 compartment (Jankovićet al., 2003; Czesnikiewicz-Guzik et al., 2008). In the experiments described below, we used the frequency of naïve and EM T cells as a correlate for the severity of T-cell immune senescence.

Our analysis revealed that JO-CR in male RM resulted in a dramatic reduction in the frequency of circulating CD8 naïve T cells and a modest decrease in the frequency of naïve CD4 T cells (Fig. 1A,B) compared to age-matched controls. Although the decrease in the frequency of CD4 naïve T cells in JO-CR male RM was not considerable, a statistically significant increase in the frequency of EM T cells in both the CD8 and CD4 subsets was detected. We previously reported that, in contrast to CD8 T cells, age-related loss of naïve CD4 T cells results in an accumulation of CM and not EM cells (Jankovićet al., 2003; Čičin-Sain et al., 2007). Because EM cells are considered to be closer to terminal differentiation (Geginat et al., 2003), the increase in EM CD4 T cells in JO-CR male RM instead of the typical increase in CM cells could suggest an accelerated rate of T-cell senescence in these animals.

Details are in the caption following the image

Phenotypic changes in aged male and female rhesus macaques (RM) T-cell subset distribution as a consequence of caloric restriction (CR). (A and B) Percentages of naïve, central memory (CM) and effector memory (EM) subsets in CD4 and CD8 T cells found in peripheral blood in juvenile-onset CR (JO-CR), adult-onset CR (AO-CR) and age-matched control male RM. JO-CR results in accelerated loss of naïve CD8 T cells, and the accumulation of EM CD4 and CD8 T cells. (C and D) Percentages of naïve, CM and EM CD4 and CD8 T-cell subsets in JO-CR and age-matched control female RM. Data from AO-CR cohort was not included for comparison because the animals within that cohort are 5 years older than the animals within the JO-CR cohort. JO-CR resulted in a decrease in EM T cells in both CD4 and CD8 subsets, but a significant increase in naïve T cells was only observed in CD8 T cells. For all panels, mean values are shown for each group at four time points over a 42-month span. Statistical analysis was carried out using the mixed-effects model and significance is denoted by two-sided P-values above the bars.

It is also important to stress that JO-CR did not alter numbers of circulating total lymphocytes based on complete blood counts (Table 1). Thus, we can conclude that in male RM, JO-CR led to accumulation of EM T cells at the expense of naïve T cells, thereby increasing the rate of T-cell senescence. These results contrast with the improved maintenance of naïve T cells induced by AO-CR (Fig. 1A,B; Messaoudi et al., 2006) and strongly suggest that early onset of CR negatively impacts T-cell aging in this nonhuman primate species.

Table 1. Animal groups, ages and hematological analysis for the number of white blood cells, lymphocytes and neutrophils by animal group
Group No. of animals Age (years) White blood cells Lymphocytes Neutrophils
Males
 JO-CR 8 19–23 4.93 ± 1.8 1.71 ± 0.44 2.38 ± 0.98
 O-CON 18 19–23 5.09 ± 1.67 1.99 ± 0.40 2.46 ± 0.86
 OO-CR 6 36–42 5.21 ± 2.45 3.42 ± 0.48 1.82 ± 2.28
 OO-CON 6 36–38 10.93 ± 2.08 2.56 ± 0.52 4.45 ± 1.06
Females
 JO-CR 8 16–18 5.28 ± 2.16 1.75 ± 0.45 2.93 ± 1.12
 JO-CON (F) 7 16–18 4.97 ± 2.33 1.60 ± 0.48 2.90 ± 1.19
  • JO-CR, juvenile-onset caloric restriction; OO-CR, old-onset caloric restriction; JO-CON, juvenile control animals; O-CON, old control animals; OO-CON, very old control animals.

In contrast to the results described above, JO-CR in female RM resulted in decreased numbers of EM CD8 and CD4 T cells, but a significant increase in the number of naïve T cells was observed in only the CD8 subset. This difference in JO-CR outcome between the male and female cohort could be due to gender-based differences in response to CR. However, given that AO-CR exerted similar benefits in both males and females (Messaoudi et al., 2006), it is possible that the differences in outcome are due to the fact that JO-CR females were 5 years younger than the male JO-CR group at the time of tissue collection. However, a better understanding of the mechanisms underlying the different outcomes of JO-CR between male and female RM requires further studies.

Old-onset CR did not result in any changes in subset distribution in either CD4 or CD8 T cells (Supporting Fig. S1). However, OO-CR animals exhibited a reduced number of circulating white blood cells compared to age-matched controls, mediated mostly by a lower number of neutrophils (Table 1). Given that the number of circulating neutrophils was higher in the very old control animals (35–38 years of age) compared to old control animals (19–23 years of age; designations of very old and old control animals are used to highlight that there is a marked difference in ages between these two control groups of animals), it is unclear whether the CR-mediated loss of neutrophils may be detrimental or beneficial.

Taken together, these data strongly suggest that JO-CR and OO-CR in male nonhuman primates accelerate T-cell senescence. JO-CR in females, on the other hand, might exert beneficial effects; however, a fully accurate interpretation of JO-CR impact in this group will have to wait until these animals reach at least 21–23 years of age.

Reduction in T-cell repertoire diversity with JO-CR

Loss of naïve T cells due to advanced age or lymphopenia results in decreased T-cell repertoire diversity (Messaoudi et al., 2004, 2006; Weyand & Goronzy, 2006). To directly test whether the changes in naïve T-cell frequencies described above impacted T-cell repertoire diversity, we measured TCRβ chain CDR3 length polymorphism (Pannetier et al., 1993) as described previously (LeMaoult et al., 2000; Messaoudi et al., 2006). A diverse CDR3 profile is characterized with a Gaussian distribution of CDR3 sizes. With age or during infection, this distribution is often disturbed and skewed profiles marked by a dominant CDR3 length are frequently detected. In some extreme cases the Vβ family is dominated by a clonotypic expansion, which can be detected as a single dominant peak (Fig. 2A). Frequency of T-cell clonal expansions (TCE) steadily increases with age and can be used to measure the extent of T-cell senescence (Callahan et al., 1993; Posnett et al., 1994; Schwab et al., 1997; LeMaoult et al., 2000).

Details are in the caption following the image

T-cell receptor repertoire analysis of T cells obtained from juvenile-onset calorie restricted (JO-CR) and control rhesus macaques (RM). (A) Representative examples of Gaussian (left), skewed (middle) and clonal (right) CDR3 size distribution. (B) Representative examples of CDR3 length polymorphism repertoires from a JO-CR male and an old control male RM. (C, D) Prevalence of T-cell clonal expansion (TCE) in peripheral blood mononuclear cells isolated from JO-CR and control male (C) and female (D) RM was calculated as described in the Experimental procedures. Although differences do not reach statistical significance, there is increased TCE incidence in JO-CR males in agreement with reduction in prevalence of naïve T cells. On the other hand, JO-CR led to a decrease in TCE incidence in female RM in agreement with decreased number of effector memory T cells.

To assess the impact of JO-CR or OO-CR on T-cell repertoire diversity in this study, we measured the frequency of TCE in PBMC. JO-CR resulted in decreased repertoire diversity and increased prevalence of clonal expansions in male RM (Fig. 2B). Although the differences observed were not statistically significant, they were in line with the observation that JO-CR led to an increase in EM CD4 and CD8 subsets. In females JO-CR led to an increase in TCRβ CDR3 size diversity, which, although not statistically significant, corresponded to the increase in naive CD8 T cells and decreases in CD8 and CD4 EM T cells observed in these animals (Fig. 2C). No change in repertoire diversity was observed when CR was initiated late in life. This finding was not surprising since OO-CR did not affect frequency of naïve and memory T-cell subsets between OO-CR and control animals.

JO-CR increases the frequency of T cells secreting pro-inflammatory cytokines

Age-related accumulation of memory T cells in rodents (Ernst et al., 1993), humans (McNerlan et al., 2002; Zanni et al., 2003) and RM (Jankovićet al., 2003; Messaoudi et al., 2006) correlates to an increase in pro-inflammatory cytokines, which represents another hallmark of immune senescence. This state has been labeled ‘inflamm-aging’, and has been speculated to contribute significantly to several age-related morbidities such as osteoporosis, sarcopenia, atherosclerosis and certain types of cancer (De Martinis et al., 2005; Wikby et al., 2006; Vasto et al., 2007). We recently showed that AO-CR decreased the number of CM and EM T cells that secreted the inflammatory cytokines IFNγ and TNFα following polyclonal stimulation (Fig. 3A–D; Messaoudi et al., 2006). To determine how age at onset of CR impacted the frequency of inflammatory cytokine-secreting T cells, we measured the frequency of IFNγ and TNFα secreting T cells following a brief (6 h) in vitro stimulation with anti-CD3 as previously described (Jankovićet al., 2003). Cells were then stained with anti-CD8, -CD4, -CD28 and -CD95 to delineate naïve and memory T-cell subsets. Subsequently, cells were fixed, permeabilized and stained with anti-IFNγ and -TNFα antibodies.

Details are in the caption following the image

Production of pro-inflammatory cytokines tumor necrosis factor-alpha (TNFα) and interferon-gamma (IFNγ) by T-cell subsets isolated from calorie restricted (CR) and control male rhesus macaques. (A, B) percentage of central memory (CM) and effector memory (EM) CD8 T cells that secrete IFNγ (A) or TNFα (B) in response to a 6-h in vitro stimulation with anti-CD3. In contrast to adult-onset CR (AO-CR), juvenile-onset CR (JO-CR) results in increased prevalence of inflammatory cytokine-secreting memory T cells. (C, D) Percentage of CM and EM CD4 T cells that secrete IFNγ (C) or TNFα (D) in response to anti-CD3 stimulation. JO-CR results in increased frequency of inflammatory cytokine-secreting CD4 T cells as well.

Our data show that in contrast to AO-CR, JO-CR led to a significant increase in the number of CD4 CM secreting TNFα and EM CD4 T cells secreting IFNγ or TNFα. A similar trend was observed for the CD8 subset but only reached significance for the CD8 CM T cells secreting IFNγ. Since JO-CR in male monkeys also resulted in an increase in the frequency of CD4 EM and CM cells, these data strongly suggest that the overall frequency of T cells that can contribute to the inflammatory milieu is significantly higher in JO-CR male RM animals compared with controls. Interestingly, JO-CR also led to an increase in the numbers of IFNγ or TNFα secreting T cells, in female JO-CR RM (Supporting Fig. S2). This trend was statistically significant for the CD4 CM T cell secreting TNFα. While these differences did not always reach significance, a clear trend was easily detectable (Supporting Fig. S2). Finally, we detected no differences in the frequency of IFNγ or TNFα secreting T cells between OO-CR animals and their age-matched controls (data not shown).

JO-CR leads to loss of proliferative potential in T cells

Accumulation of EM T cells in the course of aging is often accompanied by a loss in proliferative potential in the T-cell compartment. We previously showed that AO-CR maintained the proliferative capacity of T cells in aged animals compared to controls (Messaoudi et al., 2006) as judged by a fraction of T cells that remained undivided upon TCR/CD3 stimulation. Furthermore, T cells from AO-CR animal underwent higher number of divisions than T cells from control animals. To examine the impact of age at CR onset on proliferative potential of circulating lymphocytes, PBMC were labeled with CFSE, stimulated with an agonistic antibody against TCR/CD3 and cultured for 4 days (Jankovićet al., 2003).

Our studies revealed that in male RM, JO-CR significantly reduced the number of dividing T cells as measured by the number of cells that remained undivided (CFSEhi) after 4 days of stimulation compared to both controls and AO-CR animals (Fig. 4A,B). This observation was true for both CD4 and CD8 T cells and especially for the CD28+ subsets. Furthermore, we determined a geometric division score that is derived from the percentage of the cells in each division and gives more weight to cells that have undergone multiple rounds of division. T cells from AO-CR animals have a positive geometric score indicative of a significant percentage of cells that underwent several (> 3) rounds of proliferation (Fig. 4C,D). T cells from JO-CR animals, on the other hand, had negative scores since most of the dividing cells remained in the first division.

Details are in the caption following the image

Proliferation of T cells isolated from calorie-restricted and control male rhesus macaques. (A, B) Percentage of CD8 (A) and CD4 (B) T cells that remained undivided as defined by CFSEhi after 4 days of stimulation with immobilized anti-CD3. In contrast to adult-onset CR (AO-CR), juvenile-onset CR (JO-CR) results in loss of proliferative capacity indicated by a higher proportion of CD8 and CD4 that remain undivided especially in the CD28+ subset. (C, D) Geometric score of T-cell divisions was calculated for CD8 (C) and CD4 (D) subsets as described in the Experimental procedures. This analysis gives increased weight to later divisions. JO-CR severely limits T cells’ ability to undergo multiple rounds of divisions.

Surprisingly, there was no difference in the number of proliferating T cells between JO-CR and control females (Supporting Fig. S3). This result was unexpected given the increase in naïve CD8 T cells and decrease in EM T cells detected in JO-CR females, and suggest that proliferative (and perhaps other) function of naïve T cells might be altered in JO-CR females. Even more surprisingly, OO-CR resulted in decreased T-cell proliferation potential of the CD4+CD28+ subset in male RM. This is evident in the number of cells that remained undivided (Fig. 5A), the percentage of cells that underwent two divisions (Fig. 5B) as well as the average number of divisions they underwent (Fig. 5C). These data suggest that OO-CR can negatively impact T-cell function in the absence of any overt phenotypic changes.

Details are in the caption following the image

Proliferation of T cells isolated from old-onset calorie restricted (OO-CR) and control animals. OO-CR leads to a diminished proliferative capacity in the absence of overt phenotypic changes in T-cell subsets as evidence by a higher percentages of CD4+CD8+ T cells that remained undivided (A), a lower percentage of cells that underwent at least two divisions (B) and a decreased average number of divisions (C). Similar differences were detected for the CD8 subset but did not reach statistical significance.

Discussion

Caloric restriction (CR) remains the only intervention that consistently increases median and maximal lifespans in short-lived mammals. While the exact mechanisms by which CR exerts its effects are not completely understood, the consensus in the field is that CR reduces the intrinsic rate of aging (Bishop & Guarente, 2007) and prevents several age-related diseases, including cancer and cardiovascular disorders. Moreover, CR protects against diabetes, autoimmunity, and neurodegenerative disorders. If these benefits translated to humans, they would not only lead to an extension in lifespan but perhaps more importantly to an improvement in the quality in life. Since long-term CR studies in humans are burdened with ethical, logistical and temporal difficulties, the long-term CR studies of nonhuman primates (RM) of both sexes and various ages have been invaluable. So far, the data from these studies suggest that CR leads to similar physiological benefits in nonhuman primates as rodents (Mattison et al., 2007) including improvement in the homeostasis and function of the T-cell arm of the immune system (Messaoudi et al., 2006).

In this study, we examined the impact of the age at onset of CR on T-cell homeostasis and function in male and female RM. Our data show that JO-CR is associated with accelerated loss of naïve T cells and accumulation of EM T cells in male RM. Moreover, JO-CR was associated with decreased T-cell repertoire diversity and an increase in frequency in T-cell clonal expansions, which we previously showed to be a predisposing factor for reduced immune response to infection (Messaoudi et al., 2004). These outcomes are in contrast to the beneficial effects exerted by CR when initiated during early adulthood. The accumulation of EM (CD28neg) T cells is a predictor of poor immune competence in old age (reviewed in Vallejo, 2005) and could also contribute to age-related co-morbidities. EM CD8 T cells have little proliferative capacity (Posnett et al., 1999; Bandres et al., 2000; Zhang et al., 2002), along with shortened telomeres (Effros et al., 2005) and are resistant to apoptosis (Vallejo et al., 1998; Spaulding et al., 1999). These cells secrete large quantities of inflammatory cytokines, allowing them to potentially participate in immune pathology (Posnett et al., 1999; Bandres et al., 2000; Zhang et al., 2002). They were reported to correlate with poor generation of protective immune responses following vaccination (Saurwein-Teissl et al., 2002) and were speculated to even interfere with such responses (Effros, 1998; Goronzy et al., 2001; Saurwein-Teissl et al., 2002). Indeed, in the RM male cohorts, and in accordance with our finding that JO-CR lead to an accumulation of EM T cells, we found an increase in the frequency of CD8 and CD4 T cells that secrete IFNγ and TNFα following polyclonal stimulation compared to controls. More importantly, JO-CR in male RM led to an increase of the prevalence of pro-inflammatory cytokine-secreting cells within both the EM and CM subsets. Finally, CR was previously shown to maintain T-cell proliferative capacity in rodents (Wolf et al., 1995; Spaulding et al., 1997b; Hursting et al., 2003), and we showed that early adult-onset CR maintains T-cell ability to undergo cell divisions in nonhuman primates (Messaoudi et al., 2006). Again, JO-CR showed deleterious effects in the male RM cohort, reducing T-cell proliferative capacity. Overall, by any measure taken, the immune system of male RM placed on CR in the juvenile period exhibited signs of exacerbated, rather than retarded and reduced, aging.

The situation was somewhat different in female RM. In these animals, JO-CR decreased the prevalence of CD4 and CD8 EM T cells and significantly increased representation of naïve cells in the CD8 compartment. The difference in JO-CR impact on memory T-cell frequency between male and female RM could be a result of genuine gender differences in immune system homeostasis during aging or, perhaps more trivially, the fact that the female cohort was, on average, 5 years younger than the males at the time of sample collection. Therefore, loss of naïve T cells could be more pronounced between 15 and 20 years of age and it is possible that in 5 years the JO-CR females would experience a more rapid loss of naïve T cells than age-matched controls. It is worth noting that JO-CR resulted in a more significant delay in skeletal muscle development and weight gain in males than females (Lane et al., 1999). This delay in development was accompanied with a more pronounced reduction in abdominal trunk fat with males experiencing a threefold decrease whereas females experience only a twofold decrease compared to controls (Lane et al., 1999). Such gender-specific differences in response to CR could impact lymphopoeisis, lymphocyte homeostasis and function as well.

More importantly, however, while phenotypic changes (increase in CD8 naïve T cells) may suggest that JO-CR could be somewhat beneficial for the female CD8 T cells, by functional criteria the treatment had detrimental or neutral effects. Specifically, female RM subject to JO-CR displayed a trend of increased frequency of IFNγ and TNFα secreting T cells, suggesting that the pro-inflammatory propensity of old T cells was not alleviated by CR under these conditions. Furthermore, female RM on JO-CR showed no benefit from CR when proliferative responses were measured. These results highlight the importance of measuring multiple phenotypic and functional parameters when evaluating and interpreting the impact of an intervention on immune senescence. Taken together, our data strongly suggest that JO-CR has the potential to increase inflamm-aging in both sexes.

The most significant features observed in the T cells of OO-CR monkeys were lymphopenia and decreased T-cell proliferative capacity. Other measurements in this cohort also revealed trends towards worsening of immune phenotype and function, but with no significant differences. We conclude that CR initiated at advanced age has no benefit for the composition of peripheral T-cell pool and function of primate T cells, and that our results suggest that the latter may be adversely affected. Given that nutritional stress of CR is likely to have other unwanted effects on the physiology of old primates (D. Ingram and J. Mattison, unpublished observations), these results at a minimum urge caution in initiating late-life CR.

It is of interest to contrast our observations to those obtained from rodent studies, where a 30–60% reduction in caloric intake early in life (shortly after weaning to 6 months of age) caused a proportionate increase in lifespan and improved several aspects of immune functions (Weindruch et al., 1982). These divergent observations may be reconciled in light of the recently published findings which showed that mice calorically restricted shortly after weaning were at increased risk from severe disease following bacterial or viral challenge compared to control animals (Sun et al., 2001; Gardner, 2005; Kristan, 2007). A potential complicating factor in interpreting results of these studies is that the disease induced by pathogens studied led to weight loss, and it is well known that the animals on CR already have depleted excess weight and fat reserves. However, another explanation is that CR initiated very early in life (shortly after weaning) is detrimental to immune function, despite phenotypic changes (such as increased percentage of naïve T cells), which would be consistent with findings presented above.

In summary, our results show that adulthood onset of CR in a nonhuman primate shows uniquely beneficial impact on homeostasis and function of the T-cell compartment, suggesting the existence of an optimal window for CR efficacy. Additional studies will be required to evaluate the relative importance of these benefits and weigh them against the increase in lifespan and improved function of other organs or systems.

Experimental procedures

Animal groups

Experimental groups consisted of control and calorie-restricted RM of both sexes, listed in Table 1. All animals were kept in conventional housing and were positive for Herpes B and Rhesus Cytomegalovirus. There were no indications that any of the groups had distinct exposure to viral or other pathogens.

Some of the animals were calorically restricted before puberty (1–2 years of age, JO-CR) or at advanced age (> 15 years, OO-CR). Male RM within the JO-CR group were 19–23 years of age during the completion of these studies. These animals were age-matched to the cohort of AO-CR animals that we recently described (Messaoudi et al., 2006). Therefore, we were able to directly compare the impact of the age at onset between all three groups of animals: control, AO-CR and JO-CR males.

JO-CR females were 17–18 years of age at the completion of the studies. We could not therefore directly compare the recently published impact of AO-CR (Messaoudi et al., 2006) to that of JO-CR on T-cell function in female RM in this study since the AO-CR cohort was 21–23 years of age. Therefore, we compared female JO-CR only to age-matched female controls. Only male RM were available for the old-onset group (OO-CR). The animals were 35–38 years old and 36–40 years old for the very old control and OO-CR groups, respectively.

T-cell phenotype

T-cell phenotype was determined using flow cytometry, as previously described (Messaoudi et al., 2006). CD8β antibody was purchased from Beckman Coulter. All remaining antibodies were purchased from BD-Pharmingen (San Diego, CA, USA). Samples were acquired using the LSRII cytometer equipped with DiVa 5.0 software (Beckton Dickinson, San Jose, CA, USA) and analyzed using FlowJo (TreeStar, Ashland, OR, USA). A minimum of 106 events were collected for each sample, lymphocyte gate positioned on small/medium lymphocytes using forward and orthogonal scatter, and single-color compensation performed per manufacturer's instructions. Naïve (N), central memory (CM) and effector/effector memory (EM) populations were defined using a combination of CD28 and CD95, as originally validated by Pitcher et al. (2002). Cells with fluorescence above that of the highest fluorescence intensity of the control samples were denoted positive for a given marker.

T-cell repertoire analysis

Analysis of complementary determining region 3 (CDR3) length polymorphism was carried out exactly as described in (Messaoudi et al., 2006). Briefly, RNA was isolated from 3 to 5 × 106 PBMC using RNA isolator (Sigma, St. Louis, MO, USA), and was used to generate cDNA following reverse transcription. PCR conditions, runoff labeling procedure and all primers were previously published (Messaoudi et al., 2006).

Intracellular cytokine staining

PBMC were stimulated with soluble RM-specific anti-CD3 mAb (clone FN18, Biosource, Invitrogen, Carlsbad, CA, USA), as well as with anti-human CD28 and CD49d (Pharmingen) for 6 h. Brefeldin A was added for the last 5 h to block cytokine secretion. At the end of the incubation, PBMC were stained with surface antibodies CD8, CD8, CD28 and CD95. The cells were then fixed and permeabilized using a kit from Pharmingen as per manufacturer's recommendation. Finally, the cells were stained with antibodies against IFNγ and TNFα, and analyzed by flow cytometry as above. PBMC stimulate with anti-human CD28 and CD49d (Pharmingen) for 6 h were used as negative controls.

T-cell proliferation assay

Details of this assay were described elsewhere (Jankovićet al., 2003; Messaoudi et al., 2006). Briefly, PBMC were labeled with CFSE then plated in the presence of plate bound anti-CD3 for 96 h, stained with CD8, CD4 and CD28, and analyzed as above. We measured both the percentage of cells that remain undivided (CFSEhi), as well as the number of divisions based on CFSE dilutions. In addition, we calculated a geometric score of division as follows: G_score = (D1 + D2 × 2 + D3 × 4 + D4 × 8 + D5 × 16 + D6 × 32-Undivided)/100. This calculation gives increasing weight as the cells undergo an increasing number of divisions.

Statistical analysis

Data were analyzed as described in our recent manuscript (Messaoudi et al., 2006). Mixed effects model was used to analyze the data and to account for observations on successive occasions in time (no more than 7-month intervals over a period of 3 years) and for animal-to-animal variation. Analysis of variance and contrast tests were used to address the questions of interest.

Acknowledgments

Supported in part by the U.S. Public Health Service Awards AG21384 (to J. N.-Z.), 5T32 AI007472-10 (I.M.) and RR0163 [to the Oregon National Primate Research Center (ONPRC)] from the National Institute on Aging, National Institute of Allergy and Infectious Diseases, and the National Institute for Research Resources, respectively, as well as by the NIA Intramural Program, NIH.

The authors wish to express appreciation for the work and dedication of April Hobbs and Ed Tilmont (NIA Intramural Research Program, Poolesville, MD, USA) as well as to Drs Doug Powell and Rick Herbert (Veterinary Research Program, NIH at Poolesville, MD, USA) and Drs Frank Kogler, Mary Zelinski, Theodore Hobbs, Jennifer Wilk and Anne Lewis and Ms (ONPRC, Beaverton, OR, USA) for the complex coordination of experiments, veterinary care of the monkeys in this study and for collection of the specimens. We in particular wish to acknowledge and remember the outstanding surgical work and the friendship and the dedication of the late Dr John Fanton (ONPRC).

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.